Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

741
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
741
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

285
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
285
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

436
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
436
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

560
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
560
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

250
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
250
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

1.1K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preparedness for <i>Candida auris</i> in Canadian Nosocomial Infection Surveillance Program (CNISP) hospitals, 2024.

Infection control and hospital epidemiology·2025
Same author

Use of Oral Antibiotic Therapy for Prosthetic Joint Infections: Considerations for Implementation of Interdisciplinary Practice Changes.

Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada·2025
Same author

Multicentre Experience on the Diagnostic Yield of PCR Testing for Bacterial Pathogens in Sterile Site Infections.

Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada·2025
Same author

A Real-Time Enzyme-Linked Aptamer Assay (RT-eELAA) for Rapid and Sensitive Detection of Viral Antigens in Saliva Using Electrochemical Readout.

Analytical chemistry·2025
Same author

Fighting Mutations with Mutations: Evolutionarily Adapting a DNA Aptamer for High-Affinity Recognition of Mutated Spike Proteins of SARS-CoV-2.

Angewandte Chemie (International ed. in English)·2024
Same author

Assessing global fungal threats to humans.

mLife·2024
Same journal

Infection by Different Clades of Candidozyma auris in a Galleria mellonella Model: Determining Virulence Levels.

Mycopathologia·2026
Same journal

In Vitro Antifungal Activity of Octenidine Against Emerging Dermatophyte Species.

Mycopathologia·2026
Same journal

Candidemia Epidemiology and Antifungal Resistance in Critically-ill Patients During and After COVID-19 Pandemic: Comparison Between Two Hospitals in Greece and Türkiye.

Mycopathologia·2026
Same journal

Long-Read Sequencing and Comparative Genome Analyses of Seven Emergomyces Type-Strains.

Mycopathologia·2026
Same journal

Refractory Dermatophytosis Caused by Trichophyton indotineae: A Case Series Highlighting Antifungal Resistance and Management Challenges.

Mycopathologia·2026
Same journal

Predominance of Fonsecaea nubica in Chromoblastomycosis: A Single-Centre Study from Southern India.

Mycopathologia·2026
See all related articles

Related Experiment Video

Updated: Oct 31, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

611

Update on Pulmonary Cryptococcosis.

Deborah Yamamura1,2, Jianping Xu3

  • 1Microbiology Department, Hamilton Regional Laboratory Medicine Program, Hamilton General Hospital, Hamilton, ON, L8L 2X2, Canada.

Mycopathologia
|June 28, 2021
PubMed
Summary
This summary is machine-generated.

Pulmonary cryptococcosis, a fungal infection, is often missed. This review covers its epidemiology, transmission, risk factors, diagnosis, and treatment, highlighting research needs.

Keywords:
Cryptococcal genotypesDiagnosisPulmonary infectionsTreatment

More Related Videos

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways
10:06

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways

Published on: December 13, 2024

559
Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans
11:07

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans

Published on: December 19, 2014

12.9K

Related Experiment Videos

Last Updated: Oct 31, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

611
Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways
10:06

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways

Published on: December 13, 2024

559
Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans
11:07

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans

Published on: December 19, 2014

12.9K

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Pulmonology

Background:

  • Pulmonary cryptococcosis is a frequent opportunistic fungal infection.
  • It affects both immunocompromised and immunocompetent individuals.
  • Caused by the human pathogenic Cryptococcus complex, comprising multiple lineages and hybrids.

Purpose of the Study:

  • To provide an update on pulmonary cryptococcosis.
  • To review recent advances in its epidemiology, transmission, risk factors, diagnostics, and therapy.
  • To identify research challenges and opportunities.

Main Methods:

  • Literature review of recent advances in pulmonary cryptococcosis.
  • Synthesis of information on epidemiology, transmission, risk factors, diagnostics, and therapy.
  • Identification of research gaps and future directions.

Main Results:

  • Pulmonary cryptococcosis remains underdiagnosed.
  • Advances have been made across epidemiology, transmission, risk factors, diagnostics, and therapy.
  • Significant research opportunities exist, bridging clinical and basic science.

Conclusions:

  • Pulmonary cryptococcosis requires increased clinical and research attention.
  • Further research is crucial to improve diagnosis and treatment outcomes.
  • Translational research is needed to address current challenges.